Optimizing anti-TNF treatments in inflammatory bowel disease
Author:
Publisher
Elsevier BV
Subject
Immunology,Immunology and Allergy
Reference60 articles.
1. Maintenance infliximab for Crohn's Disease: the ACCENT 1 randomized trial;Hanauer;Lancet,2002
2. Potential target of infliximab in autoimmune and inflammatory diseases;Atzeni;Autoimmun Rev,2007
3. Report of the ECCO pathogenesis workshop on anti-TNF therapy failures in inflammatory bowel diseases: definitions, frequency and pharmacological aspects;Allez;J Crohns Colitis,2010
4. Strategies after the failure of the first anti-tumor necrosis factor alpha agent in rheumatoid arthritis;Papagoras;Autoimmun Rev,2010
5. Infliximab for induction and maintenance therapy for ulcerative colitis;Rutgeerts;N Engl J Med,2005
Cited by 333 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Lymphocyte subsets for predicting inflammatory bowel disease progression and treatment response: a systematic review;Frontiers in Immunology;2024-08-20
2. Short term effectiveness of ustekinumab versus vedolizumab in Crohn’s disease after failure of anti-TNF agents: An observational comparative study design with a Bayesian analysis;Saudi Journal of Gastroenterology;2024-08-19
3. Electroacupuncture at Zusanli regulates the pathological phenotype of inflammatory bowel disease by modulating the NLRP3 inflammasome pathway;Immunity, Inflammation and Disease;2024-08
4. A prediction method for the individual serum concentration and therapeutic effect for optimizing adalimumab therapy in inflammatory bowel disease;Journal of Pharmacy and Pharmacology;2024-07-15
5. New targeted pharmacotherapy and experimental therapies for inflammatory bowel disease;Journal of Integrative Medicine and Research;2024-07
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3